Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn C Chafe

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Science Advances|August 28, 2021
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumorsShawn C Chafe, Frederick S Vizeacoumar, Geetha Venkateswaran, et al.
Mabs|November 23, 2021
Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIXJoey G Sheff, John F Kelly, Anna Robotham, et al.
Gastroenterology|May 13, 2019
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to HypoxiaPaul C McDonald, Shawn C Chafe, Wells S Brown, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Neuron|January 22, 2026
Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenanceNicholas Mikolajewicz, Kui Zhai, Anish Puri, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
Science Translational Medicine|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell targetWilliam T Maich, Muhammad Vaseem Shaikh, Anish Puri, et al.
Mabs|November 22, 2021
Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IXAnne E G Lenferink, Paul C McDonald, Christiane Cantin, et al.
Nature|July 1, 2026
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cellsNeil Savage, Shan Grewal, Muhammad Vaseem Shaikh, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Science Advances|August 28, 2021
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumorsShawn C Chafe, Frederick S Vizeacoumar, Geetha Venkateswaran, et al.
Mabs|November 23, 2021
Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIXJoey G Sheff, John F Kelly, Anna Robotham, et al.
Gastroenterology|May 13, 2019
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to HypoxiaPaul C McDonald, Shawn C Chafe, Wells S Brown, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Neuron|January 22, 2026
Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenanceNicholas Mikolajewicz, Kui Zhai, Anish Puri, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
Science Translational Medicine|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell targetWilliam T Maich, Muhammad Vaseem Shaikh, Anish Puri, et al.
Mabs|November 22, 2021
Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IXAnne E G Lenferink, Paul C McDonald, Christiane Cantin, et al.
Nature|July 1, 2026
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cellsNeil Savage, Shan Grewal, Muhammad Vaseem Shaikh, et al.
Pageof 4